Sign in

CIK 0001817229 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Vor Biopharma Inc.

Sign in to watch
Ticker
VOR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
811591163
Phone
617-655-6580
Business address
500 BOYLSTON STREET, SUITE 1350, BOSTON, MA, 02116
  1. 8-K Event Material agreement · Unregistered share sale · Executive or director change · Regulation FD disclosure
  2. SCHEDULE 13G Stake Statement of Beneficial Ownership
  3. 4 Returned to the company CFO returned 694,137 shares (to the company)
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 8-K Event Executive or director change
  7. 424B3 Offering Prospectus
  8. SCHEDULE 13G Stake Statement of Beneficial Ownership
  9. SCHEDULE 13D/A Stake Beneficial Ownership Report
  10. 10-Q Report Quarterly Report
  11. 8-K Event Other events
  12. 424B5 Offering Prospectus
  13. 424B5 Offering Prospectus
  14. S-3/A Offering Registration Statement
  15. SCHEDULE 13G Stake Statement of Beneficial Ownership
  16. SCHEDULE 13G Stake Statement of Beneficial Ownership
  17. 8-K Event Executive or director change · Regulation FD disclosure
  18. SCHEDULE 13D/A Stake Beneficial Ownership Report
  19. 4 Open-market sale Director sold 400,408 shares at an average $25.90 ($10,368,938)
  20. 8-K Event Regulation FD disclosure

Page 5 of 24 · 464 filings